Semaglutide 2.4 mg produces weight-independent liver benefits among individuals with metabolic dysfunction-associated steatohepatitis.

A quality improvement initiative in a hepatology clinic increased alcohol use disorder pharmacotherapy prescriptions from 10% ...

Mortality associated with chronic liver disease (CLD) and metabolic syndrome (MetS) increased substantially from 1999 to 2023 ...

Patients with lean vs nonlean metabolic dysfunction-associated steatotic liver disease (MASLD) have a significantly increased ...

Dr George Tidmarsh, the head of the FDA's drug division, stepped down Sunday after questioning a new fast-track drug approval program.

Patients with different subtypes of metabolic syndrome experience varying prevalence rates of stroke and ischemic heart disease.

The Food and Drug Administration (FDA) has moved to restrict the sale of unapproved ingestible fluoride prescription drug products, stating that action will be taken against any company marketing the ...

A machine learning model using routine lab data at 3 months postdiagnosis accurately predicted mortality or liver transplant risk in autoimmune hepatitis.

Nearly two-thirds of asymptomatic adults in a US safety-net health care system tested positive for Helicobacter pylori antibodies.

Primary OS analysis results from STELLAR-303 showed zanzalintinib + atezolizumab improved OS vs regorafenib in metastatic colorectal cancer.

The percentage of those with early-onset diverticulitis admitted for complicated diverticulitis went from 18.5% to 28.2% from 2005 to 2020.

Developers of biosimilars will no longer be required to conduct clinical trials to prove effectiveness for FDA approval.